nutriflex omega plus
b. braun melsungen ag - glukosemonohydrat / natriumfosfatdihydrat / sinkacetatdihydrat / triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider / isoleucin / leucin / lysinhydroklorid / metionin / fenylalanin / treonin / tryptofan / valin / arginin / histidinhydrokloridmonohydrat / alanin / aspartinsyre / glutaminsyre / glysin / prolin / serin / natriumhydroksid / natriumklorid / natriumacetattrihydrat / kaliumacetat / magnesiumacetattetrahydrat / kalsiumkloriddihydrat - infusjonsvæske, emulsjon
nutriflex omega special
b. braun melsungen ag - glukosemonohydrat / natriumfosfatdihydrat / sinkacetatdihydrat / triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider / isoleucin / leucin / lysinhydroklorid / metionin / fenylalanin / treonin / tryptofan / valin / arginin / histidinhydrokloridmonohydrat / alanin / aspartinsyre / glutaminsyre / glysin / prolin / serin / natriumhydroksid / natriumklorid / natriumacetattrihydrat / kaliumacetat / magnesiumacetattetrahydrat / kalsiumkloriddihydrat - infusjonsvæske, emulsjon
virbagen omega
virbac s.a. - rekombinant omega interferon av feline opprinnelse - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. hos katter infisert av fiv var dødeligheten lav (5%) og ble ikke påvirket av behandlingen.
copemyl 40 mg/ ml
mylan ab - glatirameracetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 40 mg/ ml
copemyl 20 mg/ ml
mylan ab - glatirameracetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 20 mg/ ml
omacor 1000 mg
basf - omega-3-syreetylestere 90 - kapsel, myk - 1000 mg
iomeron 400 mg i/ ml
bracco imaging spa - jomeprol - injeksjonsvæske, oppløsning - 400 mg i/ ml
iomeron 150 mg i/ ml
bracco imaging spa - jomeprol - injeksjonsvæske, oppløsning - 150 mg i/ ml
iomeron 200 mg i/ ml
bracco imaging spa - jomeprol - injeksjonsvæske, oppløsning - 200 mg i/ ml
iomeron 250 mg i/ ml
bracco imaging spa - jomeprol - injeksjonsvæske, oppløsning - 250 mg i/ ml